Scientific Article
previous document  unige:138403  next document
add to browser collection
Title

Perturbations in ataxia telangiectasia mutant signaling pathways after drug-induced acute liver failure and their reversal during rescue of animals by cell therapy

Authors
Bandi, Sriram
Joseph, Brigid
Singhania, Rohit
Wu, Yao-Ming
Cheng, Kang
Gupta, Sanjeev
Published in The American journal of pathology. 2011, vol. 178, no. 1, p. 161-174
Abstract Superior insights into molecular mechanisms of liver failure, which are not fully understood, will help strategies for inducing liver regeneration. We examined hepatotoxic mechanisms in mice homozygous for the severe combined immune deficiency mutation in the protein kinase, DNA-activated, catalytic polypeptide. Mice were treated with rifampicin, phenytoin, and monocrotaline. The ensuing acute liver failure was characterized by serological, histological, and mRNA studies. Subsequently, we studied whether transplantation of hepatocytes could rescue animals with liver failure. We found extensive liver damage in these animals, with mortality over several days. The expression of multiple hepatic genes was rapidly altered, including those representing pathways in oxidative/metabolic stress, inflammation, DNA damage-repair, and ataxia telangiectasia mutant (Atm) signaling pathways. This led to liver cell growth arrest involving cyclin-dependent kinase inhibitor 1A. Transplantation of hepatocytes with microcarriers in the peritoneal cavity efficiently rescued animals with liver failure. Molecular abnormalities rapidly reversed, including in hepatic Atm and downstream signaling pathways; and residual hepatocytes overcame cyclin-dependent kinase inhibitor 1A-induced cell growth arrest. Reseeding of the liver with transplanted hepatocytes was not required for rescue because native hepatocytes overcame cell growth-arrest to regenerate the liver. This likely resulted from paracrine signaling from hepatocytes in the peritoneal cavity. We concluded that Atm signaling played critical roles in the pathological features of liver failure. These studies should help redirect examination of pathophysiologic and therapeutic mechanisms in liver failure.
Keywords AnimalsAtaxia Telangiectasia Mutated ProteinsCell Cycle Proteins/geneticsCell ProliferationCyclin-Dependent Kinase Inhibitor p21/geneticsCytochrome P-450 CYP3A/biosynthesisDNA Damage/geneticsDNA Repair/geneticsDNA-Binding Proteins/geneticsGene ExpressionHepatocytes/transplantationLiver Failure, Acute/chemically induced/genetics/pathology/surgeryLiver Regeneration/geneticsMiceMice, SCIDMonocrotaline/toxicityPhenytoin/toxicityProtein-Serine-Threonine Kinases/geneticsRatsRats, Inbred F344Rifampin/toxicitySignal TransductionTumor Suppressor Proteins/genetics
Identifiers
PMID: 21224054
Full text
Research group Création de tissus par bio-ingénieurie et régénération d'organes (1021)
Citation
(ISO format)
BANDI, Sriram et al. Perturbations in ataxia telangiectasia mutant signaling pathways after drug-induced acute liver failure and their reversal during rescue of animals by cell therapy. In: The American Journal of Pathology, 2011, vol. 178, n° 1, p. 161-174. doi: 10.1016/j.ajpath.2010.11.001 https://archive-ouverte.unige.ch/unige:138403

154 hits

72 downloads

Update

Deposited on : 2020-07-14

Export document
Format :
Citation style :